Amphastar Pharma (AMPH) Tops Q1 EPS by 26c

Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $1.04, $0.26 better than the analyst estimate of $0.78. Revenue for the quarter came in at $171.8 million versus the consensus estimate of $176.36 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• BofA lists top 5 themes driving next $1tn in incremental semi sales